ABILIFY MAINTENA

Google image searchProduct monograph

Active ingredient

aripiprazole, 300 MG/VIAL

DIN: 02420864

Dosage form(s): POWDER FOR SUSPENSION, SUSTAINED-RELEASE, KIT

Route(s) of administration: INTRAMUSCULAR

Description: 200MG/ML AFTER RECONSTITUTION. SYRINGE AND DILUENT INCLUDED IN THE KIT

Schedule: Prescription

Company: OTSUKA PHARMACEUTICAL CO LTD

Date: 27-MAR-2014

ATC:

Reference brand drug: Abilify

Pharmaceutical standard: MFR

Search on Google